Blueprint Medicines Corp (BPMC)
90.46
+0.13
(+0.14%)
USD |
NASDAQ |
Dec 24, 16:00
Blueprint Medicines Free Cash Flow: -250.52M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals Inc | -1.352B |
| PTC Therapeutics Inc | -274.19M |
| Biomarin Pharmaceutical Inc | 300.88M |
| Regeneron Pharmaceuticals Inc | 3.319B |
| SpringWorks Therapeutics Inc | -221.15M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.64M |
| Cash from Investing (Quarterly) | 29.95M |
| Cash from Financing (Quarterly) | 18.38M |
| Free Cash Flow Per Share (Quarterly) | -0.2156 |
| Free Cash Flow to Equity (Quarterly) | -13.32M |
| Free Cash Flow to Firm (Quarterly) | -6.009M |
| Free Cash Flow Yield | -4.41% |